Literature DB >> 34151769

Quality of Life Interventions in Breast Cancer Survivors: State of the Art in Targeted Rehabilitation Strategies.

Marco Invernizzi1,2, Alessandro de Sire3, Konstantinos Venetis4,5, Emanuele Cigna6, Stefano Carda7, Margherita Borg1, Carlo Cisari2, Nicola Fusco4,5.   

Abstract

Breast cancer is the most common malignant tumor and the most prevalent cause of mortality in women. Advances in early diagnosis and more effective adjuvant therapies have improved the long-term survival of these patients. Pharmacotherapies and intrinsic tumor-related factors may lead to a wide spectrum of treatment-related disabling complications, such as breast cancer-related lymphedema, axillary web syndrome, persistent pain, bone loss, arthralgia, and fatigue. These conditions have a detrimental impact on the health-related quality of life of survivors. Here, we sought to provide a portrait of the role that rehabilitation plays in breast cancer survivors. Particular emphasis has been put in terms of recovering function, improving independence in activities of daily living, and reducing disability. This complex scenario requires a precision medicine approach to provide more effective decision-making and adequate treatment compliance. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Breast cancer; axillary web syndrome; bone loss; breast cancer-related lymphedema; cancer-related fatigue; fatigue; lymphedema; pain; quality of life; rehabilitation

Mesh:

Year:  2022        PMID: 34151769     DOI: 10.2174/1871520621666210609095602

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  10 in total

1.  Longitudinal Assessment of Physical Activity, Fitness, Body Composition, Immunological Biomarkers, and Psychological Parameters During the First Year After Diagnosis in Women With Non-Metastatic Breast Cancer: The BEGYN Study Protocol.

Authors:  Cosima Zemlin; Caroline Stuhlert; Julia Theresa Schleicher; Carolin Wörmann; Laura Altmayer; Marina Lang; Laura-Sophie Scherer; Ida Clara Thul; Carolin Müller; Elisabeth Kaiser; Regine Stutz; Sybelle Goedicke-Fritz; Laura Ketter; Michael Zemlin; Gudrun Wagenpfeil; Georges Steffgen; Erich-Franz Solomayer
Journal:  Front Oncol       Date:  2021-10-19       Impact factor: 6.244

2.  Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC).

Authors:  Nicola Fusco; Antonio Rizzo; Leopoldo Costarelli; Alfredo Santinelli; Bruna Cerbelli; Cristian Scatena; Ettore Macrì; Francesca Pietribiasi; Giulia d'Amati; Anna Sapino; Isabella Castellano
Journal:  Pathologica       Date:  2022-04-13

3.  Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study.

Authors:  Angeline Ginzac; Maureen Bernadach; Ioana Molnar; Martine Duclos; Emilie Thivat; Xavier Durando
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

4.  The non-fatal burden of cancer in Belgium, 2004-2019: a nationwide registry-based study.

Authors:  Vanessa Gorasso; Geert Silversmit; Marc Arbyn; Astrid Cornez; Robby De Pauw; Delphine De Smedt; Ian Grant; Grant M A Wyper; Brecht Devleesschauwer; Niko Speybroeck
Journal:  BMC Cancer       Date:  2022-01-13       Impact factor: 4.430

5.  Physical Therapies for Psychosomatic Symptoms and Quality of Life Induced by Aromatase Inhibitors in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Xue-Ying Zhu; Zhong Li; Cong Chen; Ru-Li Feng; Bai-Ru Cheng; Ruo-Yi Liu; Rui-Ting Wang; Li Xu; Yue Wang; Xin Tao; Peng Zhao
Journal:  Front Oncol       Date:  2021-11-12       Impact factor: 6.244

6.  Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials.

Authors:  Alessandro de Sire; Lorenzo Lippi; Konstantinos Venetis; Stefania Morganti; Elham Sajjadi; Claudio Curci; Antonio Ammendolia; Carmen Criscitiello; Nicola Fusco; Marco Invernizzi
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

7.  Effects of intensive physiotherapy on Quality of Life (QoL) after pancreatic cancer resection: a randomized controlled trial.

Authors:  Dirk Weyhe; Dennis Obonyo; Verena Uslar; Navid Tabriz
Journal:  BMC Cancer       Date:  2022-05-09       Impact factor: 4.638

Review 8.  Axillary Web Syndrome in Breast Cancer Women: What Is the Optimal Rehabilitation Strategy after Surgery? A Systematic Review.

Authors:  Lorenzo Lippi; Alessandro de Sire; Luigi Losco; Kamal Mezian; Arianna Folli; Mariia Ivanova; Lorenzo Zattoni; Stefano Moalli; Antonio Ammendolia; Carmine Alfano; Nicola Fusco; Marco Invernizzi
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

9.  A pilot study of cognitive behavioural therapy integrated with activity pacing for fatigued breast cancer patients undergoing chemotherapy in Ethiopia.

Authors:  Mikiyas Amare Getu; Changying Chen; Adamu Addissie; Edom Seife; Panpan Wang; Eva Johanna Kantelhardt
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

Review 10.  The Role of Emotion-Related Abilities in the Quality of Life of Breast Cancer Survivors: A Systematic Review.

Authors:  Ilaria Durosini; Stefano Triberti; Lucrezia Savioni; Valeria Sebri; Gabriella Pravettoni
Journal:  Int J Environ Res Public Health       Date:  2022-10-04       Impact factor: 4.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.